Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News MMTEC Inc MTC

Technology Software - Application
Mmtec Inc is a China-based company primarily engaged in asset management services based on platforms. The Company is principally engaged in providing complete suite trading solutions, including fund creation, distribution, custody, trading and settlement services, to help these financial institutions accelerate their integration into overseas markets. The Company's systems include ETN counter... see more

Recent & Breaking News (NDAQ:MTC)

Servier Announces Promising Phase 1 Data for Vorasidenib in IDH Mutant Low-Grade Glioma Published in Clinical Cancer Research

PR Newswire June 16, 2021

Accuray Expands CyberKnife® System Versatility with Integration of RaySearch's RayStation Treatment Planning System

PR Newswire June 16, 2021

DocGo Expands Partnership with Thomas Jefferson University Hospital to Transport Patients in Philadelphia

PR Newswire June 16, 2021

iFOLIO® Powers Digital Healthcare Innovation for New Mothers in Florida

PR Newswire June 16, 2021

Dewpoint Appoints Michael Wagner, Ph.D., as Senior Vice President of Chemistry and Drug Discovery

PR Newswire June 16, 2021

4Front Ventures Corp. Makes $75,000 Contribution to Elk Grove Village, Illinois to Support Local Community and Its Health and Wellness Initiatives

PR Newswire June 16, 2021

Zhongchao Inc. Partners with a Subsidiary of AbbVie Inc. (NYSE: ABBV) for Medical Education Services

PR Newswire June 16, 2021

KAHR Announces $46.5 Million Financing to Advance its Multifunctional Immunotherapeutic Pipeline

PR Newswire June 16, 2021

Elanco Announces Agreement to Acquire Kindred Biosciences

PR Newswire June 16, 2021

Movember Honors Dads For First Ever Virtual Comedy Show

PR Newswire June 16, 2021

Shoppers Drug Mart donates more than $500,000 to Canadian Mental Health Association; Funds to support innovative new approach to improving mental health in communities

Canada NewsWire June 16, 2021

Inteliquet(TM) Announces Comprehensive Hematology And Oncology To Join Consortium To Drive Better Patient Matching In Clinical Trials

PR Newswire June 16, 2021

United Therapeutics Announces FDA Acceptance of Tyvaso DPI(TM) New Drug Application For Priority Review

PR Newswire June 16, 2021

Clarivate Report Demonstrates that Nations or Institutions with Diverse Research Priorities Respond More Comprehensively to Unprecedented Scientific Challenges

Canada NewsWire June 16, 2021

Global Forum on Nicotine: Experts call for worldwide access to safer nicotine to reduce deadly smoking-related harms

Canada NewsWire June 16, 2021

Brains Bioceutical Corp. completes a USD $31.9 Million Capital Raise with Lead Investor DSM Venturing

Canada NewsWire June 16, 2021

Harbour BioMed and Dana-Farber Cancer Institute Collaborate to Advance Novel Biotherapies for Cancer Treatment

PR Newswire June 16, 2021

REGEN-COV(TM) (casirivimab and imdevimab) Phase 3 RECOVERY Trial Meets Primary Outcome, Improving Survival in Hospitalized COVID-19 Patients Lacking an Immune Response to SARS-CoV-2

PR Newswire June 16, 2021

Mnemo Therapeutics Announces Euro75 million Series A to Accelerate Next Generation Integrated CAR-T and Epigenetic Targeting Platform

PR Newswire June 16, 2021

ACT Against COVID: The Alliance for Comprehensive Testing (ACT) Launches Effort to Improve Public Health Through Widespread Testing Initiatives, including COVID-19 Testing

PR Newswire June 16, 2021